Literature DB >> 14985365

Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome.

M Andrew Nesbit1, Michael R Bowl, Brian Harding, Asif Ali, Alejandro Ayala, Carol Crowe, Angus Dobbie, Geeta Hampson, Ian Holdaway, Michael A Levine, Robert McWilliams, Susan Rigden, Julian Sampson, Andrew J Williams, Rajesh V Thakker.   

Abstract

The hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome is an autosomal dominant disorder caused by mutations of the dual zinc finger transcription factor, GATA3. The C-terminal zinc finger (ZnF2) binds DNA, whereas the N-terminal finger (ZnF1) stabilizes this DNA binding and interacts with other zinc finger proteins, such as the Friends of GATA (FOG). We have investigated seven HDR probands and their families for GATA3 abnormalities and have identified two nonsense mutations (Glu-228 --> Stop and Arg-367 --> Stop); two intragenic deletions that result in frameshifts from codons 201 and 355 with premature terminations at codons 205 and 370, respectively; one acceptor splice site mutation that leads to a frameshift from codon 351 and a premature termination at codon 367; and two missense mutations (Cys-318 --> Arg and Asn-320 --> Lys). The functional effects of these mutations, together with a previously reported GATA3 ZnF1 mutation and seven other engineered ZnF1 mutations, were assessed by electrophoretic mobility shift, dissociation, yeast two-hybrid and glutathione S-transferase pull-down assays. Mutations involving GATA3 ZnF2 or adjacent basic amino acids resulted in a loss of DNA binding, but those of ZnF1 either lead to a loss of interaction with specific FOG2 ZnFs or altered DNA-binding affinity. These findings are consistent with the proposed three-dimensional model of ZnF1, which has separate DNA and protein binding surfaces. Thus, our results, which expand the spectrum of HDR-associated GATA3 mutations and report the first acceptor splice site mutation, help to elucidate the molecular mechanisms that alter the function of this zinc finger transcription factor and its role in causing this developmental anomaly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985365     DOI: 10.1074/jbc.M401797200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Differential regulation of osteoblast activity by Th cell subsets mediated by parathyroid hormone and IFN-gamma.

Authors:  Nathan Young; Natallia Mikhalkevich; Ying Yan; Di Chen; Wei-ping Zheng
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

2.  A novel heterozygous deletion frameshift mutation of GATA3 in a Japanese kindred with the hypoparathyroidism, deafness and renal dysplasia syndrome.

Authors:  H Kobayashi; M Kasahara; M Hino; H Yoshimura; S Takahara; K Ikeda; C Son; T Iwakura; A Yoshimoto; T Ishihara; Y Ogawa
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

Review 3.  Role of the GATA family of transcription factors in endocrine development, function, and disease.

Authors:  Robert S Viger; Séverine Mazaud Guittot; Mikko Anttonen; David B Wilson; Markku Heikinheimo
Journal:  Mol Endocrinol       Date:  2008-01-03

4.  Crystal structures of multiple GATA zinc fingers bound to DNA reveal new insights into DNA recognition and self-association by GATA.

Authors:  Darren L Bates; Yongheng Chen; Grace Kim; Liang Guo; Lin Chen
Journal:  J Mol Biol       Date:  2008-07-02       Impact factor: 5.469

5.  Vitamin D deficiency in a patient with HDR syndrome.

Authors:  Ifigenia Kostoglou-Athanassiou; Dimitrios Stefanopoulos; Areti Karfi; Panagiotis Athanassiou
Journal:  BMJ Case Rep       Date:  2015-07-08

6.  GATA3 mutation in a family with hypoparathyroidism, deafness and renal dysplasia syndrome.

Authors:  Zi-Yang Zhu; Qiao-Li Zhou; Shi-Ning Ni; Wei Gu
Journal:  World J Pediatr       Date:  2014-08-15       Impact factor: 2.764

7.  A novel mutation in the GATA3 gene of a Japanese patient with PTH-deficient hypoparathyroidism.

Authors:  Tasuku Saito; Seiji Fukumoto; Nobuaki Ito; Hisanori Suzuki; Takashi Igarashi; Toshiro Fujita
Journal:  J Bone Miner Metab       Date:  2008-12-05       Impact factor: 2.626

8.  A novel mutation in the GCM2 gene causing severe congenital isolated hypoparathyroidism.

Authors:  Daniel Doyle; Susan M Kirwin; Katia Sol-Church; Michael A Levine
Journal:  J Pediatr Endocrinol Metab       Date:  2012       Impact factor: 1.634

9.  CLC-5 and KIF3B interact to facilitate CLC-5 plasma membrane expression, endocytosis, and microtubular transport: relevance to pathophysiology of Dent's disease.

Authors:  Anita A C Reed; Nellie Y Loh; Sara Terryn; Jonathan D Lippiat; Chris Partridge; Juris Galvanovskis; Siân E Williams; Francois Jouret; Fiona T F Wu; Pierre J Courtoy; M Andrew Nesbit; Patrik Rorsman; Olivier Devuyst; Frances M Ashcroft; Rajesh V Thakker
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-25

10.  SEDLIN forms homodimers: characterisation of SEDLIN mutations and their interactions with transcription factors MBP1, PITX1 and SF1.

Authors:  Jeshmi Jeyabalan; M Andrew Nesbit; Juris Galvanovskis; Richard Callaghan; Patrik Rorsman; Rajesh V Thakker
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.